icon-folder.gif   Conference Reports for NATAP  
 
  The International Liver Congress™
EASL - European Association for the
Study of the Liver
Barcelona, Spain
13-17 April 2016
Back grey_arrow_rt.gif
 
 
 
C-EDGE: HEAD 2 HEAD - Efficacy and Safety of Elbasvir/Grazoprevir versus Sofosbuvir /Pegylated Interferon/Ribavirin (PR) in Treatment-Naïve and Prior PR Treatment Failure Subjects with Chronic HCV GT1 or 4 Infection
 
 
  Reported by Jules Levin
EASL 2016 Barcelona April 14-17
 
Jan Sperl, Gabor Horvath, Waldemar Halota, Juan Arenas Ruiz-Tapiador, Anca Streinu-Cercel, Ligita Jancoriene, Klara Werling, Hege Kileng, Seyfettin Koklu, Jan Gerstoft, Sushma Patel, Jingjun Qiu, Ernest Assante-Appiah, Janice Wahl, Bach-Yen Nguyen, Eliav Barr, Heather L. Platt

conclusion

EASL2

EASL3

EASL4

EASL5

EASL6

EASL7